Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report.
Ratanatharathorn V, Lorvidhaya V, Kraipiboon P, Sirachainan E, Maoleekoonpairoj S, Phromratanapongse P, Cheirsilpa A, Tangkaratt S, Srimuninnimit V, Pattaranutaporn P, Lertsanguansinchai P. Ratanatharathorn V, et al. Among authors: cheirsilpa a. J Med Assoc Thai. 2000 Jan;83(1):85-92. J Med Assoc Thai. 2000. PMID: 10710874 Clinical Trial.
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
Ratanatharathorn V, Lorvidhaya V, Maoleekoonpairoj S, Phromratanapongse P, Sirilerttrakul S, Kraipiboon P, Cheirsilpa A, Tangkaratt S, Srimuninnimit V, Pattaranutaporn P. Ratanatharathorn V, et al. Among authors: cheirsilpa a. Lung Cancer. 2001 Feb-Mar;31(2-3):257-65. doi: 10.1016/s0169-5002(00)00171-9. Lung Cancer. 2001. PMID: 11165405 Clinical Trial.
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.
Laohavinij S, Maoleekoonpairoj S, Cheirsilpa A, Maneechavakajorn J, Sirachainant E, Arpornvivat W, Jaisathaporn K, Ratanatharathorn V. Laohavinij S, et al. Among authors: cheirsilpa a. Lung Cancer. 1999 Dec;26(3):175-85. doi: 10.1016/s0169-5002(99)00089-6. Lung Cancer. 1999. PMID: 10598928 Clinical Trial.
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH. Chua DT, et al. Among authors: cheirsilpa a. Cancer. 1998 Dec 1;83(11):2270-83. Cancer. 1998. PMID: 9840526 Clinical Trial.
Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.
Tattersall MH, Lorvidhaya V, Vootiprux V, Cheirsilpa A, Wong F, Azhar T, Lee HP, Kang SB, Manalo A, Yen MS, et al. Tattersall MH, et al. Among authors: cheirsilpa a. J Clin Oncol. 1995 Feb;13(2):444-51. doi: 10.1200/JCO.1995.13.2.444. J Clin Oncol. 1995. PMID: 7844607 Clinical Trial.
High-dose mitomycin C: activity in hepatocellular carcinoma.
Cheirsilpa A, Leelasethakul S, Auethaveekiat V, Maoleekulpriroj S, Kangsumrit N, Thanakaravit P, Phanthumjida P. Cheirsilpa A, et al. Cancer Chemother Pharmacol. 1989;24(1):50-3. doi: 10.1007/BF00254105. Cancer Chemother Pharmacol. 1989. PMID: 2541938
14 results